Michael Lichardi: New Publication on Complex Anticoagulation Management in Critical Care
Michael Lichardi, Unit Based Pharmacist at Hackensack Meridian Health, Advisory Board Member of Gaits to Healing, shared a post on LinkedIn about a recent article he and his collegues co-authored, published in American Journal of Health-System Pharmacy, adding:
“Excited to share our publication in the American Journal of Health-System Pharmacy!
This case report covers a challenging anticoagulation scenario involving adrenal hemorrhage, apixaban reversal, active DVT, and heparin-induced thrombocytopenia in a critically ill patient.
Really grateful for the opportunity to work on this with an awesome team and contribute to the literature in critical care pharmacy.
Big thanks to my co-authors Shannon Moriarty and Haley Nicholas.”
Title: Adrenal hemorrhage requiring apixaban reversal in the setting of active deep vein thrombosis and heparin-induced thrombocytopenia: A case report
Authors: Michael Lichardi, Shannon Moriarty, Haley Nicholas

Stay updated on scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series